BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27531892)

  • 1. MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma.
    Ji J; Xu M; Tu J; Zhao Z; Gao J; Chen M; Song J; Zhu H; Cheng X; Hui J; Lan X; Yang X
    Oncotarget; 2016 Sep; 7(37):60303-60309. PubMed ID: 27531892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.
    Xie K; Ma H; Liang C; Wang C; Qin N; Shen W; Gu Y; Yan C; Zhang K; Dai N; Zhu M; Wu S; Wang H; Dai J; Jin G; Shen H; Hu Z
    Oncotarget; 2015 Dec; 6(40):42781-92. PubMed ID: 26543233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis.
    Li XD; Li ZG; Song XX; Liu CF
    Pathology; 2010 Dec; 42(7):669-73. PubMed ID: 21080878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population.
    An J; Liu J; Liu L; Liu Y; Pan Y; Huang M; Qi F; Wen J; Xie K; Ma H; Shen H; Hu Z
    PLoS One; 2014; 9(4):e93707. PubMed ID: 24751683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A miR-182 variant and risk of hepatocellular carcinoma in a southern Chinese population.
    Qiu M; Liu Y; Lin Q; Zhou Z; Jiang Y; Huo R; Liang X; Yu X; Cao J; Zhou X; Yu H
    Hum Genomics; 2020 Oct; 14(1):38. PubMed ID: 33059751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
    Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of MicroRNA Polymorphisms With Hepatocellular Carcinoma in an Iranian Population.
    Farokhizadeh Z; Dehbidi S; Geramizadeh B; Yaghobi R; Malekhosseini SA; Behmanesh M; Sanati MH; Afshari A; Moravej A; Karimi MH
    Ann Lab Med; 2019 Jan; 39(1):58-66. PubMed ID: 30215231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Function Variant at miR-501 Alters Susceptibility to Hepatocellular Carcinoma in a Chinese Han Population.
    Liu Y; Chai Y; Zhang J; Tang J
    Cell Physiol Biochem; 2016; 38(6):2500-8. PubMed ID: 27310251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miR-149C>T polymorphisms on the risk of hepatocellular carcinoma in a Chinese population.
    Liu MF; Chen WQ; He YZ; Gu YL
    Genet Mol Res; 2014 Sep; 13(3):7184-9. PubMed ID: 25222224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
    Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rs767649 polymorphism in the promoter of miR-155 contributes to the decreased risk for cervical cancer in a Chinese population.
    Wang S; Cao X; Ding B; Chen J; Cui M; Xu Y; Lu X; Zhang Z; He A; Jin H
    Gene; 2016 Dec; 595(1):109-114. PubMed ID: 27717891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
    Chen P; Zhao X; Ma L
    Mol Cell Biochem; 2013 Nov; 383(1-2):49-58. PubMed ID: 23842624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population.
    Jiang ZC; Tang XM; Zhao YR; Zheng L
    Tumour Biol; 2014 Dec; 35(12):12345-52. PubMed ID: 25179842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution melting analysis reveals genetic polymorphisms in microRNAs confer hepatocellular carcinoma risk in Chinese patients.
    Qi JH; Wang J; Chen J; Shen F; Huang JT; Sen S; Zhou X; Liu SM
    BMC Cancer; 2014 Aug; 14():643. PubMed ID: 25176041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma.
    Song Y; Xing H; Zhou L; Zhang N; Yang M
    Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of two inflammation-related polymorphisms with susceptibility to hepatocellular carcinoma: a meta-analysis.
    Liu J; Xie B; Chen S; Jiang F; Meng W
    BMC Med Genet; 2014 Aug; 15():92. PubMed ID: 25108400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma.
    Hua KT; Liu YF; Hsu CL; Cheng TY; Yang CY; Chang JS; Lee WJ; Hsiao M; Juan HF; Chien MH; Yang SF
    Sci Rep; 2017 Jun; 7(1):4466. PubMed ID: 28667334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.